Nabi Biopharmaceuticals opens Florida manufacturing plant

The facility, the first vaccine manufacturing plant in the southeastern U.S., is intended to produce the firm's StaphVAX vaccine to prevent hospital-acquired bacterial infections, assuming it receives FDA approval. Nabi Pharmaceuticals has applied for European approval, but U.S. approval was delayed after a previous clinical trial did not reach the intended efficacy goal of 12 months.

View Full Article in:

Boca Raton News (Fla.) · Sun-Sentinel (Fort Lauderdale, Fla.)

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Senior Director, Biostatistics
Edwards Lifesciences
Irvine, CA
Diagnostic Technician
Marlborough, MA
Test Technician
Marlborough, MA
Associate - Food and Drug
Keller and Heckman LLP
Washington, DC
Senior Paralegal - Research & Development, and Medical
Boehringer Ingelheim
Ridgefield, CT